GlassScriptPhysician profile
Antonio R De Thomas Cabrera
NPI 1255318986
$483.97
in general payments reported to CMS, 2019-2025
10 companies · $150 in 2025
The $150 reported for 2025 was more than what a typical Diagnostic Ultrasound provider received nationally (typical 2025 total: $95.70).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $15.24 · 2022: $97.07 · 2023: $52.77 · 2024: $63.12 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $112.93 | 2019-2024 | Xarelto, Erleada |
| Boston Scientific Corporation | $107.90 | 2025 | Avvigo Guidance System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $79.95 | 2022 | |
| Abbott Laboratories | $58.94 | 2019 | |
| Genentech USA, INC. | $42.53 | 2025 | Polivy |
| Abbvie INC. | $19.44 | 2024 | |
| Pbg Puerto Rico LLC | $17.89 | 2019 | |
| Merck Sharp & Dohme LLC | $17.12 | 2022 | |
| Medtronic, INC. | $14.51 | 2024 | Na |
| E.R. Squibb & Sons, L.L.C. | $12.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antonio De Thomas Cabrera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.